跳至主要内容
临床试验/NCT02305927
NCT02305927已完成3 期

Trial of Vitamin D in HIV Progression, Birth Outcomes, and Child Health

Wafaie Fawzi1 个研究点 分布在 1 个国家目标入组 2,300 人开始时间: 2015年6月15日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
2,300
试验地点
1
主要终点
Proportion of stunted infants (height-for-age z-score < -2)

研究概览

简要总结

The purpose of this study to assess the effect of maternal vitamin D3 (cholecalciferol) supplementation on maternal HIV progression, small-for-gestational age infants, and infant stunting at 12 months postpartum for HIV-infected Tanzanian pregnant women who are receiving highly active antiretroviral therapy (HAART).

详细描述

The study is a randomized, double-blind, placebo-controlled trial of maternal vitamin D3 (cholecalciferol) supplementation starting in the second trimester (12-27 weeks gestation) and continuing until 12 months postpartum among HIV-infected Tanzanian pregnant women who are receiving HAART. Eligible individuals are randomized to receive a) a vitamin D3 regimen consisting 3,000 IU of vitamin D3 taken orally once daily starting in the second trimester and continuing until 12 months postpartum or b) a placebo regimen taken orally once daily starting in the second trimester and continuing until 12 months postpartum. Mothers will be followed at study visits during pregnancy and mother/infant pairs will attend study visits from birth until trial discharge at 12 months postpartum.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged ≥18 years old
  • HIV-positive
  • Receiving HAART
  • Pregnant and of 12-27 weeks gestation (Second Trimester)
  • Calcium levels in the normal physiologic range (≤2.6 mmol/L)

排除标准

  • Enrolled in any other clinical trial

结局指标

主要结局

Proportion of stunted infants (height-for-age z-score < -2)

时间窗: 12 months postpartum (1 year of age)

Proportion of participants experiencing maternal HIV progression

时间窗: Second Trimester until 12 months post partum

Proportion of small-for-gestational age infants

时间窗: Birth

次要结局

未报告次要终点

研究者

发起方
Wafaie Fawzi
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Wafaie Fawzi

Professor of Nutrition, Epidemiology, and Global Health

Harvard School of Public Health (HSPH)

研究点 (1)

Loading locations...

相似试验